Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 May 1;64(6):1.
doi: 10.1167/iovs.64.6.1.

Editorial: International Myopia Institute White Paper Series 2023

Nina Tahhan  1   2 , James S Wolffsohn  3 , Padmaja Sankaridurg  1   2 , Jost B Jonas  4   5 , Mark A Bullimore  6 , Ian Flitcroft  7   8 , Lisa A Ostrin  6 , Christine Wildsoet  9 , Serge Resnikoff  1   2
Affiliations
Editorial

Editorial: International Myopia Institute White Paper Series 2023

Nina Tahhan et al. Invest Ophthalmol Vis Sci. .

Erratum in

No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosure: N. Tahhan, None; J.S. Wolffsohn, AOS (C), Aston Vision Sciences (S), Bausch & Lomb (C), Alcon (C, F), Allergan (F), CooperVision (C, F), CSIDryEye (C), DopaVision (C), Eyoto (S), Johnson & Johnson Vision (F), Rayner (F), M2C Pharmaceuticals (C, F), Medmont (C), Novartis (C, F), NuVision (C, F), Santen (C), Scope Ophthalmics (C, F), SightGlass (C, F), Théa (C, F), Topcon (F), The Eye Doctor (F), Wolffsohn Research Limited (S); P. Sankaridurg, EssilorLuxottica (F, R), Shamir (F), CooperVision (F, R), SEED (R), Oculus (F), SightGlass Vision (R), Mark Ennovy (R), Myopia Control - Optical and Pharmaceutical (P), J.B. Jonas, Myopia Control Agent (P); M.A. Bullimore, Alcon Research (C), CooperVision (C), Corneagen (C), EssilorLuxottica (C), Euclid Systems (C), Eyenovia (C), Genentech (C), Johnson & Johnson Surgical (C), Johnson & Johnson Vision (C), Lentechs (C), Novartis (C), Oculus(C), Pentavision (C), Presbia (C), Vyluma (C), Ridgevue Publishing (O), Ridgevue Vision (O); I. Flitcroft, CooperVision (C), EssilorLuxottica (C), Johnson & Johnson Vision (C), Vyluma (C), Thea (C), Ocumetra (O), Myopia control monitoring tools and devices (P); L.A. Ostrin, None; C. Wildsoet, None; S. Resnikoff, None

References

    1. Flitcroft DI, He M, Jonas JB, et al. .. IMI – Defining and classifying myopia: A proposed set of standards for clinical and epidemiologic studies. Invest Ophthalmol Vis Sci. 2019; 60(3): M20–M30. - PMC - PubMed
    1. Gifford KL, Richdale K, Kang P, et al. .. IMI – Clinical management guidelines report. Invest Ophthalmol Vis Sci. 2019; 60(3): M184–M203. - PubMed
    1. Jones L, Drobe B, Gonzalez-Meijome JM, et al. .. IMI – Industry guidelines and ethical considerations for myopia control report. Invest Ophthalmol Vis Sci. 2019; 60(3): M161–M183. - PubMed
    1. Tedja MS, Haarman AEG, Meester-Smoor MA, et al. .. IMI – Myopia genetics report. Invest Ophthalmol Vis Sci. 2019; 60(3): M89–M105. - PMC - PubMed
    1. Troilo D, Smith EL 3rd, Nickla DL, et al. .. IMI – Report on experimental models of emmetropization and myopia. Invest Ophthalmol Vis Sci. 2019; 60(3): M31–M88. - PMC - PubMed

Publication types